
Cost per course: €25
Venue: Hermes
Course Organiser: E. Souied FRANCE
08.00 |
E. Souied FRANCE Stagardt and FFM |
08.12 |
FRANCE Best and AOFVD |
08.24 |
FRANCE Cone dystrophy |
08.36 |
E. Souied FRANCE Pattern dystrophy |
08.48 |
FRANCE X-linked retinoschisis |
09.00 |
E. Souied FRANCE Inherited white dots on the retina |
09.12 |
Discussion |
09.30 |
End of course |
Venue: Erato
Course Organiser: C. De Laey BELGIUM
08.00 |
N. Leveziel FRANCE Spectral domain OCT in normal subjects |
08.20 |
C. De Laey BELGIUM How to interpret an OCT scan |
08.40 |
C. De Laey, A. Leys BELGIUM The importance of macular maps illustrated by a few cases |
08.50 |
A. Gaudric FRANCE OCT in Age-related Macular Degeneration |
09.20 |
Discussion |
09.30 |
End of course |
Venue: Gallieni 6
Course Organiser: C. Creuzot-Garcher FRANCE
08.00 |
P. Massin FRANCE Clinical cases of tractional retinal detachment in diabetic patients |
08.15 |
J.P. Berrod FRANCE Clinical cases of retinal detachment in phakic or pseudophakic patients |
08.30 |
R. Tadayoni FRANCE Clinical cases of retinal detachment in myopic patients |
08.45 |
M. de Smet BELGIUM Complicated cases of uveitic patients |
09.00 |
C. Creuzot-Garcher FRANCE Clinical cases of macular diseases |
09.15 |
Discussion |
09.30 |
End of course |
The aim of this course dedicated to students preparing for the European Board of Ophthalmology
(EBO) exam is to emphasise the interest of semiology to choose from various therapeutic options.
Speakers will focus on clinical presentation of patients suffering from retinal diseases. Different
cases of retinal detachment will be presented, with the various therapeutic options, and a discussion
based on preoperative video presentation. Cases of patients suffering from macular diseases with
the indication of surgery will be discussed.
Venue: Hermes
Course Organiser: C. Egan UK
11.00 |
C. Egan UK Introduction and welcome |
11.05 |
S. Aldington UK Grading diabetic retinopathy: Which is the best severity scale to use and why? |
11.25 |
R. Johnston UK Electronic record keeping in the management of diabetic retinopathy: Moving towards best practice |
11.45 |
P. Massin FRANCE The practice and challenges of diabetic retinopathy screening in France |
12.05 |
C. Egan UK Challenging cases presenting to a screening programme |
12.25 |
Panel closing comments |
12.30 |
End of course |
Venue: Erato
Course Organiser: B. Corcóstegui SPAIN
11.00 |
SPAIN Risk factors |
11.12 |
C. Mateo SPAIN Membrane peeling |
11.24 |
J. Garcia-Arumi SPAIN Subretinal PVR |
11.36 |
T. Wolfensberger SWITZERLAND Relaxing retinopathy |
11.48 |
B. Aylward UK Fluid-gas or fluid silicon oil exchange |
12.00 |
SPAIN Lensectomy and pseudophakic management |
12.12 |
SPAIN Discussion |
12.30 |
End of course |
Venue: Hermes
Course Organiser: C. Mateo SPAIN
14.30 |
Introduction |
14.40 |
C. Mateo SPAIN Dealing with 23 gauge incisions |
14.50 |
SPAIN Keratoplasty and pars plana vitrectomy: Long-term results |
15.00 |
B. Aylward UK Achieving success with vitrectomy for retinal detachment |
15.10 |
A. Gaudric FRANCE Macular retinoschisis: Evolution and treatment |
15.20 |
UK Why do I have to consider heavy silicone oil and which? |
15.30 |
GERMANY What do I do in massive submacular hemorrhage in the antiangiogenic drugs era? |
15.40 |
Discussion |
16.00 |
End of course |
Venue: Erato
Course Organiser: G. Holder UK
14.30 |
G. Holder UK An introduction to electrophysiological testing |
14.50 |
B. Leroy BELGIUM ERGs and pattern ERGs in inherited and acquired disease |
15.20 |
G. Holder UK Visual evoked potentials, multi-focal ERGs and ERGs beyond the ISCEV: Standard in inherited and acquired disease |
15.50 |
Discussion |
16.00 |
End of course |
The first lecture will address the nature of the tests, how they are performed and what they can show.
The two subsequent lectures will be case-based and address how the tests are used clinically in diagnosis and management.
Venue: Erato
Course Organiser: A. Laidlaw UK
16.30 |
A. Laidlaw UK Introduction |
16.32 |
E. Stefánsson ICELAND Pathology and pathophysiology of proliferative retinopathy |
16.42 |
M. Mohamed UK Proliferative retinopathy |
17.01 |
S.L. Oberstein THE NETHERLANDS Vitreous haemorrhage |
17.14 |
T. Williamson UK Tractional retinal detachment |
17.25 |
A. Laidlaw UK Vitrectomy in florid proliferation, use of anti-VEGF agents prior to diabetic vitrectomy |
17.36 |
T. Williamson UK Complications of diabetic vitrectomy |
17.47 |
A. Laidlaw UK Vitrectomy for diabetic macular edema |
18.00 |
End of course |